Madrigal Pharmaceuticals Inc
Stock Chart, Company Information, and Scan Results
$396.32(as of Nov 3, 4:00 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Madrigal Pharmaceuticals Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$396.32
Ticker SymbolMDGL
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees915
CountyUSA
Market Cap$9,961.5M
EBIDTA-321.1M
10-Day Moving Average434.42
P/E Ratio-35.53
20-Day Moving Average449.20
Forward P/E Ratio65.36
50-Day Moving Average494.64
Earnings per Share-12.85
200-Day Moving Average499.10
Profit Margin-15.91%
RSI21.09
Shares Outstanding23.1M
ATR21.66
52-Week High615.00
Volume1,978,542
52-Week Low387.34
Book Value523.7M
P/B Ratio22.06
Upper Keltner497.93
P/S Ratio9.00
Lower Keltner400.47
Next Earnings DateUnknown
Cash Surplus-81.5M
Next Ex-Dividend DateUnknown
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.
Madrigal Pharmaceuticals Inc In Our Stock Scanner
As of Nov 03, 2026
Scan Name: Oversold Stocks Scan Type: Stock Indicator Scans
As of ---
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---
Scan Name: 52-Week LowScan Type: Stock Fundamentals
As of ---
Scan Name: Undervalued Blue ChipsScan Type: Stock Fundamentals
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.